The prevalence and determinants of impaired fasting glucose in the population of Taiwan

BMC Public Health

Mei Chang Yeh¹  Chen-Mei Chen¹ 

[1] Department of Nursing, College of Medicine, National Taiwan University, Taipei, Taiwan

关键词: Taiwan;    Epidemiology;    Adult;    Prevalence;    Impaired fasting glucose (IFG);   

Others  :  1161509
DOI  :  10.1186/1471-2458-13-1123

 received in 2013-04-05, accepted in 2013-11-27,  发布年份 2013

【 摘 要 】

Background

A current prevalence and relevant risk factors for impaired fasting glucose (IFG) have been reported by various ethnic groups and countries. By contrast, nationwide data for the incidence of IFG in Taiwan have not been presented in the past 15 years. The aim for this manuscript was to estimate the prevalence of IFG and associated risk factors in the population of Taiwan.

Methods

For this cross-sectional research, we used a nationally representative sample (N = 2604) obtained from the 2005–2008 Nutrition and Health Survey in Taiwan (NAHSIT), and adopted a stratified multistage sampling design. The tools employed for data collection included questionnaire interviews, anthropometry measurements, and laboratory analysis.

Results

The prevalence of IFG among adults in Taiwan is 35.8% (a fasting glucose level between 100 and 125 mg/dl is considered abnormal). An estimated number of people with IFG is 6.5 million. A higher prevalence of IFG is observed in men younger than 65 years compared to women. However, this trend is reversed for the elderly population. The factors significantly associated with IFG include the following: sex, age, overweight (27 > BMI ≥ 24), obesity (BMI ≥ 27), waist circumference (men ≥ 90 cm, women ≥ 80 cm), hypertension, and hyperlipidemia.

Conclusions

IFG among adults in Taiwan is a health concern that requires attention. We recommend targeting the younger population, especially overweight and obese men between the ages of 19 and 40 years, to provide applicable healthy lifestyle counseling and services. Furthermore, appropriate screening of elderly people is required to detect undiagnosed IFG cases and provide early intervention and treatment.

【 授权许可】

   
2013 Chen and Yeh; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Whiting DR, Guariguata L, Weil C, Shaw J: IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 2011, 94:311-321.
• [2]Chang HY, Hsu CC, Pan WH, Liu WL, Cheng JY, Tseng CH, Bai CH, Yeh WT, Hurng BS: Gender differences in trends in diabetes prevalence from 1993 to 2008 in Taiwan. Diabetes Res Clin Pract 2010, 90:358-364.
• [3]Barrett-Connor E: The oral glucose tolerance test, revisited. Eur Heart J 2002, 23:1229-1231.
• [4]American Diabetes Association: Standards of medical care in diabetes–2012. Diabetes Care 2012, 35:S11-S63.
• [5]Unwin N, Shaw J, Zimmet P, Alberti K: Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabetic Med 2002, 19:708-723.
• [6]Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997, 20:1183-1197.
• [7]Wen CP, Cheng TY, Tsai SP, Hsu HL, Wang SL: Increased mortality risks of pre-diabetes (impaired fasting glucose) in Taiwan. Diabetes Care 2005, 28:2756-2761.
• [8]Laaksonen DE, Lindström J, Lakka TA, Eriksson JG, Niskanen L, Wikström K, Aunola S, Keinänen-Kiukaanniemi S, Laakso M, Valle TT: Physical activity in the prevention of type 2 diabetes. Diabetes 2005, 54:158-165.
• [9]Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, Kitzmiller J, Knowler WC, Lebovitz H, Lernmark A: Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003, 26:3160-3167.
• [10]Rao SS, Disraeli P, McGregor T: Impaired glucose tolerance and impaired fasting glucose. Am Fam Physician 2004, 69:1961-1968.
• [11]Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New Engl J Med 2002, 346:393-403.
• [12]Mustafa N, Kamarudin NA, Ismail AA, Khir AS, Ismail IS, Musa KI, Kadir KA, Yaacob NA, Ali O, Isa SHM: Prevalence of abnormal glucose tolerance and risk factors in urban and rural Malaysia. Diabetes Care 2011, 34:1362-1364.
• [13]Kim SM, Lee JS, Lee J, Na JK, Han JH, Yoon DK, Baik SH, Choi DS, Choi KM: Prevalence of diabetes and impaired fasting glucose in Korea: Korean national health and nutrition survey 2001. Diabetes Care 2006, 29:226-231.
• [14]Balde NM, Diallo I, Balde MD, Barry IS, Kaba L, Diallo MM, Kake A, Camara A, Bah D, Barry MM: Diabetes and impaired fasting glucose in rural and urban populations in Futa Jallon (Guinea): prevalence and associated risk factors. Diabetes Metab 2007, 33:114-120.
• [15]Qin X, Li J, Zhang Y, Ma W, Fan F, Wang B, Xing H, Tang G, Wang X, Xu X: Prevalence and associated factors of diabetes and impaired fasting glucose in Chinese hypertensive adults aged 45 to 75 years. PLoS One 2012, 7:1-8.
• [16]Khambalia A, Phongsavan P, Smith BJ, Keke K, Dan L, Fitzhardinge A, Bauman AE: Prevalence and risk factors of diabetes and impaired fasting glucose in Nauru. BMC Public Health 2011, 11:719. BioMed Central Full Text
• [17]Lecomte P, Vol S, Caces E, Born C, Chabrolle C, Lasfargues G, Halimi JM, Tichet J: Five-year predictive factors of type 2 diabetes in men with impaired fasting glucose. Diabetes Metab 2007, 33:140-147.
• [18]Qian Y, Lin Y, Zhang T, Bai J, Chen F, Zhang Y, Luo S, Shen H: The characteristics of impaired fasting glucose associated with obesity and dyslipidaemia in a Chinese population. BMC Public Health 2010, 10:139. BioMed Central Full Text
• [19]Chen HY, Hwang LC: The association between impaired fasting glucose level and the risk of development diabetes- a 10-year follow-up of 1189 employees of single hospital. J Formos Med Assoc 2005, 15:191-201.
• [20]Tu SH, Chen C, Hsieh YT, Chang HY, Yeh CJ, Lin YC, Pan WH: Design and sample characteristics of the 2005–2008 Nutrition and Health Survey in Taiwan. Asia Pac J Clin Nutr 2011, 20:225-237.
• [21]Lin YC, Pan WH: Bone mineral density in adults in Taiwan: results of the nutrition and health survey in Taiwan 2005–2008 (NAHSIT 2005–2008). Asia Pac J Clin Nutr 2011, 20:283-291.
• [22]Wang JL, Weng YL, Pan WH, Kao MD: Trends and nutritional status for magnesium in Taiwan from NAHSIT 1993 to 2008. Asia Pac J Clin Nutr 2011, 20:266-274.
• [23]Obesity definitions and principles http://www.hpa.gov.tw/BHPNet/Web/HealthTopic/TopicArticle.aspx?No=201111010004&parentid=201109290001 webcite
• [24]Criteria of adults with metabolic http://www.hpa.gov.tw/BHPNet/Web/HealthTopic/TopicArticle.aspx?No=200712250123&parentid=200712250023 webcite
• [25]Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT: Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 2003, 42:1206-1252.
• [26]High cholesterol prevention the manual-dyslipidemia diagnosis and treatment and prevention guidelines http://www.hpa.gov.tw/BHPNet/Portal/file/ThemeULFile/20070820300000004/0001.pdf webcite
• [27]Glümer C, Jørgensen T, Borch-Johnsen K: Prevalences of diabetes and impaired glucose regulation in a Danish population. Diabetes Care 2003, 26:2335-2340.
• [28]Sheu WH, Kwok CF, Tsai ST, Chuang LM, Lin JD, Tai TY, Ho LT: Prediabetes and cardiovascular disease : its implications and management suggestions. J Intern Med Taiwan 2008, 19:401-409.
• [29]Nestel P, Lyu R, Low LP, Sheu WH, Nitiyanant W, Saito I, Tan CE: Metabolic syndrome: recent prevalence in east and southeast Asian populations. Asia Pac J Clin Nutr 2007, 16:362-367.
• [30]Faeh D, William J, Tappy L, Ravussin E, Bovet P: Prevalence, awareness and control of diabetes in the Seychelles and relationship with excess body weight. BMC Public Health 2007, 7:163-169. BioMed Central Full Text
• [31]Pan WH, Wu SJ, Yeh CJ, Chuang SY, Chang HY, Yeh NH, Hsieh YT: Diet and healthy trend in Taiwan. Asia Pac J Clin Nutr 2011, 20:238-250.
• [32]Shen DC, Yen CS: Prediabetes. Taiwan Med J 2009, 52:20-23.
• [33]Larsson H, Lindgärde F, Berglund G, Ahrén B: Prediction of diabetes using ADA or WHO criteria in post-menopausal women: a 10-year follow-up study. Diabetologia 2000, 43:1224-1228.